These molecular abnormalities of SCCO have similar molecular and genetic manifestations to malignant rhabdoid tumors; hence some researchers believed that SCCOHT could be classified as ovarian malignant rhabdoid tumor and be diagnosed using SMARCA4 immunostaining and genetic testing as diagnostic criteria (22). This evidence concerns the gene SMARCA4 and ovarian small cell carcinoma.